您的购物车当前为空
别名 CBB1007 trihydrochloride
CBB1007 trihydrochloride is a selective, reversible, and substrate competitive LSD1 inhibitor (IC50: 5.27 μM for hLSD1).

CBB1007 trihydrochloride is a selective, reversible, and substrate competitive LSD1 inhibitor (IC50: 5.27 μM for hLSD1).
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 1,280 | 待询 | |
| 5 mg | ¥ 1,930 | 待询 | |
| 10 mg | ¥ 2,930 | 待询 | |
| 50 mg | ¥ 6,960 | 待询 | |
| 100 mg | ¥ 10,800 | 待询 | |
| 200 mg | 待询 | 待询 | |
| 500 mg | 待询 | 待询 | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,730 | 待询 |
| 产品描述 | CBB1007 trihydrochloride is a selective, reversible, and substrate competitive LSD1 inhibitor (IC50: 5.27 μM for hLSD1). |
| 体外活性 | CBB1007 efficiently can block LSD1-mediated demethylation of H3K4Me2 and H3K4Me (IC50 ≤ 5 μM) with no effect on H3K4Me3 and H3K9Me2, and LSD2 and JARID1A activities. Increases H3K4Me2 and H3K4Me contents (IC50 ≤ 5 μM), and causes activation of epigenetically suppressed CHRM4/M4-ArchR and SCN3A genes in F9 cells (IC50 ≤ 3.74 μM). |
| 别名 | CBB1007 trihydrochloride |
| CAS No. | 2070015-03-9 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度信息 | DMSO: 54 mg/mL, Sonication is recommended. |
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 1.67 mg/mL, Sonication is recommeded. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多